Beauty Multinationals Lean On North America As China’s COVID Shutdowns Upset Growth
Executive Summary
China’s “zero-COVID” policy and associated lockdowns were felt deeply in the 2022 first quarter by cosmetics giants in neighboring countries and global market leaders. Effects likely will be more pronounced in Q2.
You may also be interested in...
Lauder Lowers FY23 Outlook On ‘Temporary Pause’ In China, Tightening Of US Inventory
Estee Lauder Companies says fiscal 2023 second-quarter sales will decline high double digits due to ongoing COVID-19 restrictions in China, tightening inventory by some US retailers, and a strong US dollar. The firm expects improvement in the back half of the year, but has adjusted full-year guidance.
Coty’s China Momentum Reflects Consumer ‘Obsession’ With Prestige; Q3 Sales Up 15%
Expecting China to evolve into the largest prestige beauty market in the world, Coty believes it is well-positioned to benefit as one of the fastest-growing beauty firms in the country as consumers increasingly flock to fragrance. The firm’s Asia Pacific sales grew 9% in the fiscal third quarter, reported, to $158.1m.
Lauder Slashes FY 2022 Outlook On China Woes Despite ‘Makeup Renaissance’ In Other Regions
Estee Lauder says a strict COVID-related lockdown in China prompted an adjustment in full-year sales projections to 7%-9% growth, about half of its was earlier estimate. Global fragrance sales jumped reported 28% in latest quarter to $579m and makeup sales increased 9% to $1.11bn.